Modern Medicine Now Top Story

In the pipeline: What’s new and what’s coming in optometry technologyKeeping patients informed on the latest procedures and equipment available to treat their disorders is half the battle, says Paul Karpecki, OD, FAAO, at American Optometric Association’s Optometry’s Meeting.
Dara Torres: Don’t put an age limit on your dreamsDara Torres, the oldest and 12-time Olympic medalist, says your dreams shouldn’t have age limits. She addressed attendees of the American Optometric Association at Optometry's Meeting 2017, detailing her Olympic comeback after seven years away from the sport and giving birth.
Top 10 primary care doctors to follow on TwitterSome physicians embrace social media and use it to assist their peers and patients. Here are 10 of the best primary care accounts you should follow.
Top 8 things doctors need to know about 2018 MACRA proposed rule
Top 8 things doctors need to know about 2018 MACRA proposed ruleThe Centers for Medicare & Medicaid Services (CMS) has released its proposed rule for year two of the Quality Payment Program portion of the Medicare Access and CHIP Reauthorization Act (MACRA), affecting who’s eligible and how quality scores are calculated.
Q&A: Rohit Sharma, OD President, Southern Eye Specialists, Atlanta, GAOptometry missions, salsa dancing, customer service, and partying in Thailand
Getting comfortable with cloud storage
Getting comfortable with cloud storageLearn about options for personal and practice data storage
How tear proteomics can help optometryODs undervalue ocular point-of-care tear testing
10 tips to enhance scleral contact lens successImprove your scleral fitting skills and your patients’ quality of life
CDC recommends cholera vaccine for certain U.S. travelersThe federal agency supports a vaccine fast-tracked by the FDA for adults traveling to one of the more than 50 countries where cholera is endemic.
Cost, perception remain barriers in pharmacy-based vaccinationPharmacies can help reach populations that have difficulty in using traditional channels for vaccines, but obstacles remain.